Mitazalimab

DB15225InvestigationalProtein Based Therapies

Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 5
Curator reviewed
Code names: ADC-1013

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

8Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mitazalimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.